Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

353 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis.
Anders HJ, Ryu M. Anders HJ, et al. Kidney Int. 2011 Nov;80(9):915-925. doi: 10.1038/ki.2011.217. Epub 2011 Aug 3. Kidney Int. 2011. PMID: 21814171 Review.
A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation.
Anders HJ, Vielhauer V, Frink M, Linde Y, Cohen CD, Blattner SM, Kretzler M, Strutz F, Mack M, Gröne HJ, Onuffer J, Horuk R, Nelson PJ, Schlöndorff D. Anders HJ, et al. J Clin Invest. 2002 Jan;109(2):251-9. doi: 10.1172/JCI14040. J Clin Invest. 2002. PMID: 11805137 Free PMC article.
Phenotyping renal leukocyte subsets by four-color flow cytometry: characterization of chemokine receptor expression.
Vielhauer V, Anders HJ, Pérez de Lema G, Luckow B, Schlöndorff D, Mack M. Vielhauer V, et al. Among authors: anders hj. Nephron Exp Nephrol. 2003;93(2):e63. doi: 10.1159/000068517. Nephron Exp Nephrol. 2003. PMID: 12629274
Chemokines and chemokine receptors are involved in the resolution or progression of renal disease.
Anders HJ, Vielhauer V, Schlöndorff D. Anders HJ, et al. Kidney Int. 2003 Feb;63(2):401-15. doi: 10.1046/j.1523-1755.2003.00750.x. Kidney Int. 2003. PMID: 12631106 Review.
CC chemokine ligand 5/RANTES chemokine antagonists aggravate glomerulonephritis despite reduction of glomerular leukocyte infiltration.
Anders HJ, Frink M, Linde Y, Banas B, Wörnle M, Cohen CD, Vielhauer V, Nelson PJ, Gröne HJ, Schlöndorff D. Anders HJ, et al. J Immunol. 2003 Jun 1;170(11):5658-66. doi: 10.4049/jimmunol.170.11.5658. J Immunol. 2003. PMID: 12759447
Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice.
Anders HJ, Vielhauer V, Eis V, Linde Y, Kretzler M, Perez de Lema G, Strutz F, Bauer S, Rutz M, Wagner H, Gröne HJ, Schlöndorff D. Anders HJ, et al. FASEB J. 2004 Mar;18(3):534-6. doi: 10.1096/fj.03-0646fje. Epub 2004 Jan 20. FASEB J. 2004. PMID: 14734643
Chemokine receptor CCR1 but not CCR5 mediates leukocyte recruitment and subsequent renal fibrosis after unilateral ureteral obstruction.
Eis V, Luckow B, Vielhauer V, Siveke JT, Linde Y, Segerer S, Perez De Lema G, Cohen CD, Kretzler M, Mack M, Horuk R, Murphy PM, Gao JL, Hudkins KL, Alpers CE, Gröne HJ, Schlöndorff D, Anders HJ. Eis V, et al. Among authors: anders hj. J Am Soc Nephrol. 2004 Feb;15(2):337-47. doi: 10.1097/01.asn.0000111246.87175.32. J Am Soc Nephrol. 2004. PMID: 14747380
Signaling danger: toll-like receptors and their potential roles in kidney disease.
Anders HJ, Banas B, Schlöndorff D. Anders HJ, et al. J Am Soc Nephrol. 2004 Apr;15(4):854-67. doi: 10.1097/01.asn.0000121781.89599.16. J Am Soc Nephrol. 2004. PMID: 15034087 Review.
Late onset of treatment with a chemokine receptor CCR1 antagonist prevents progression of lupus nephritis in MRL-Fas(lpr) mice.
Anders HJ, Belemezova E, Eis V, Segerer S, Vielhauer V, Perez de Lema G, Kretzler M, Cohen CD, Frink M, Horuk R, Hudkins KL, Alpers CE, Mampaso F, Schlöndorff D. Anders HJ, et al. J Am Soc Nephrol. 2004 Jun;15(6):1504-13. doi: 10.1097/01.asn.0000130082.67775.60. J Am Soc Nephrol. 2004. PMID: 15153561
Targeting the chemokine network in renal inflammation.
Eis V, Vielhauer V, Anders HJ. Eis V, et al. Among authors: anders hj. Arch Immunol Ther Exp (Warsz). 2004 May-Jun;52(3):164-72. Arch Immunol Ther Exp (Warsz). 2004. PMID: 15247883 Review.
353 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback